促性腺激素释放激素类似物对特发性中枢性性早熟女童体重指数影响的长期观察

袁金娜; 梁黎; 蔡锡顶; 李珍; 白敏; 顾承萍

PDF(970 KB)

中国当代儿科杂志 ›› 2011, Vol. 13 ›› Issue (11) : 896-899.

论著·临床研究

促性腺激素释放激素类似物对特发性中枢性性早熟女童体重指数影响的长期观察

袁金娜，梁黎，蔡锡顶，李珍，白敏，顾承萍

作者信息 +

Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study

YUAN Jin-Na, LIANG Li, CAI Xi-Ding, LI Zhen, BAI Min, GU Cheng-Ping

Author information +

文章历史 +

摘要

目的：动态研究促性腺激素释放激素类似物（GnRHa）治疗对特发性中枢性性早熟（ICPP）女童体重指数（BMI）的影响。方法：对2003年1月至2006年1月确诊为ICPP 的134例女童进行随访研究，其中57例给予GnRHa治疗（疗程1.69±0.43年），测量治疗前、治疗结束时及近成年身高时的身高、体重、骨龄及BMI等，并与未治疗组（77例）比较。结果：（1）GnRHa治疗组在治疗结束时的预测终身高标准差分值（SDS）较治疗前明显升高（P0.05），且近成年身高SDS明显高于靶身高SDS（P0.05）；近成年身高时的BMI SDS比治疗前和未治疗组明显降低（P<0.01），但治疗前、治疗结束时及近成年身高时BMI平均值都在±1SD内，处于正常范围。结论：GnRHa对改善ICPP女童终身高有显著疗效；GnRHa治疗后的BMI改变处于正常范围。

Abstract

OBJECTIVE: To study the impact of gonadotropinreleasing hormone analogs (GnRHa) on body mass index (BMI) in girls with idiopathic central precocious puberty (ICPP). METHODS: One hundred and thirty-four girls with ICPP were enrolled. Fifty-seven out of the 134 girls were treated with GnRHa for 1.69±0.43 years. The height, weight, bone age and BMI were measured before treatment, at the end of the treatment and after reaching near adult height and compared with those in the untreated 77 girls. RESULTS: The adult predicted height standard deviation score (SDS) at the end of treatment was significantly higher than that before treatment (P0.05). With GnRHa treatment, the near-adult height SDS was higher than the target height SDS (P0.05). A significant reduction in the BMI was observed when reaching the near-adult height in the GnRHa treatment group compared to the level of pretreatment and the untreated group (P<0.01). However, the BMI in the GnRHa treatment group before treatment, at the end of the treatment and after reaching near adult height remained in the normal range (±1 SD). CONCLUSIONS: GnRHa may improve the final height in girls with ICPP. The alterations of BMI after GnRHa therapy fluctuate in a normal range.

导出引用

袁金娜，梁黎，蔡锡顶，李珍，白敏，顾承萍. 促性腺激素释放激素类似物对特发性中枢性性早熟女童体重指数影响的长期观察[J]. 中国当代儿科杂志. 2011, 13(11): 896-899

YUAN Jin-Na, LIANG Li, CAI Xi-Ding, LI Zhen, BAI Min, GU Cheng-Ping. Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study[J]. Chinese Journal of Contemporary Pediatrics. 2011, 13(11): 896-899

中图分类号： R725.8

参考文献

［1］Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, et al. Consensus statement on the use of gonadotropinreleasing hormone analogs in children［J］. Pediatrics, 2009, 123(4): e752-e762.

［2］Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, et al. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty data at near final height［J］. Neuroendocrinology, 2009, 89(4): 441-447.

［3］Paterson WF, McNeill E, Young D, Donaldson MDC. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty［J］. Clin Endocrinol (Oxf), 2004, 61(5): 626-634.

［4］中华医学会儿科学分会内分泌遗传代谢学组.中枢性（真性）性早熟诊治指南［J］.中华儿科杂志,2007,45(6): 426-427.

［5］李辉，季成叶，宗心南，张亚钦.中国0-18岁儿童、青少年身高、体重的标准化生长曲线；中国0-18岁儿童、青少年体块指数的生长曲线［J］.中华儿科杂志, 2009, 47(7):487-498.

［6］盛晓阳，薛敏波，沈理笑，洪昭毅. 上海0-17岁儿童骨骼强度与白人儿童的比较. 达能营养中心第五届学术会议论文集［C］.［2011-08-03］. http://www.danoneinstitute.org.cn/show.asp?ArtID=963&channel=publications&sub_channel=discourse.

［7］Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R, et al. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function［J］. J Clin Endocrinol Metab, 2008, 93(1): 190-195.

［8］陈少科，范歆，唐晴. GnRHa治疗中枢性性早熟女童对终身高的影响［J］.中国当代儿科杂志, 2009, 11(5): 374-376.

［9］Traggiai C, Perucchin PP, Zerbini K, Gastaldi R, De Biasio P, Lorini R. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height［J］. Eur J Endocrinol, 2005, 152(3): 463-464.

［10］Kaplowitz PB, Slora EJ, Wasserman RC, Pedlow SE, Herman-Giddens ME. Earlier onset of puberty in girls: relation to increased body mass index and race［J］. Pediatrics, 2001, 108(2): 347-353.

［11］Wang Y. Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls［J］. Pediatrics, 2002, 110(5): 903-910.

［12］Poomthavorn P, Suphasit R, Mahachoklertwattana P. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment［J］. Gynecol Endocrinol, 2011, 27(8): 524-528.

［13］Bertelloni S, Mul D. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men［J］. Asian J Androl, 2008, 10(4):525-534.

［14］Lazar L, Padoa A, Phillip M. Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity［J］. J Clin Endocrinol Metab, 2007, 92(9): 3483-3489.